US · HNGE
Hinge Health, Inc.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- San Francisco, CA 94105
- Website
- hingehealth.com
Price · as of 2026-07-02
$84.05
Market cap 4.25B
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $3.79 | $0.00 | |||
| 2025 | $44.86 | $47.39 | $677.92 | $0.00 | $0.00 |
Line items
Line items
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| HNGE | Hinge Health, Inc. | $84.05 | 4.25B | -44% | +304% | — | — | -6.72 | 9.38 | 6.04 | -5.91 | 5058.00% |
| AKRO | Akero Therapeutics, Inc. | $54.65 | 4.5B | — | — | — | — | -11.22 | 3.77 | — | -7.43 | — |
| CRNX | Crinetics Pharmaceuticals… | $36.01 | 3.8B | +55% | -21% | — | — | -8.22 | 3.86 | 705.95 | -6.17 | 42166.00% |
| DYN | Dyne Therapeutics, Inc. | $18.56 | 3.07B | — | — | — | — | -3.68 | 1.85 | — | -1.74 | — |
| IMVT | Immunovant, Inc. | $33.50 | 6.88B | — | — | — | — | -6.14 | 3.59 | — | -4.18 | — |
| INDV | Indivior Pharmaceuticals … | $36.61 | 4.57B | +212% | +59% | -79% | -44% | 19.04 | -40.38 | 3.23 | 12.71 | 429.00% |
| LNTH | Lantheus Holdings, Inc. | $99.62 | 6.49B | +5% | -21% | -70% | -70% | 22.05 | 4.73 | 3.34 | 14.36 | 50.00% |
| OSCR | Oscar Health, Inc. | $22.33 | 5.79B | +106% | +14,681% | — | — | -8.28 | 3.75 | 0.31 | -0.28 | 2750.00% |
| PRAX | Praxis Precision Medicine… | $352.63 | 7.46B | -62% | — | — | — | -24.53 | 8.47 | — | -22.57 | -10000.00% |
| VKTX | Viking Therapeutics, Inc. | $32.19 | 3.74B | — | — | — | — | -10.44 | 5.88 | — | -7.76 | — |
| WGS | GeneDx Holdings Corp. | $50.15 | 1.49B | +222% | -38% | -86% | — | -94.92 | 6.47 | 4.67 | 298.22 | 3997.00% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($339.63 ÷ $84.05) − 1 = +304.08% (DCF, example).